| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.9 |
| mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.9 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.0031 |
0.9 |